Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.22.2.2
Condensed Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current assets    
Cash $ 907,917 $ 1,486,972
Prepaid expenses 341,502 353,541
Total current assets 1,249,419 1,840,513
Other noncurrent assets 233,482
Investments held in Trust Account 238,428,531 236,903,949
TOTAL ASSETS 239,677,950 238,977,944
Current liabilities    
Accounts payable and accrued expenses 312,471 71,214
Accrued offering costs 1,098
Total current liabilities 312,471 72,312
Deferred underwriting fee payable 8,050,000 8,050,000
Warrant liabilities 790,000 10,189,334
TOTAL LIABILITIES 9,152,471 18,311,646
Commitments and contingencies (see Note 6)  
Class A ordinary shares subject to possible redemption, $0.0001 par value; 500,000,000 shares authorized; 23,000,000 shares at redemption value as of September 30, 2022 and December 31, 2021 238,428,531 236,903,949
Shareholders’ Deficit    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized, no shares issued and outstanding (excluding 23,000,000 shares subject to possible redemption) as of September 30, 2022 and December 31, 2021
Class B ordinary shares, each having a par or nominal value of approximately $0.00009; 53,333,345.5 shares authorized; 7,666,667 shares issued and outstanding as of September 30, 2022 and December 31, 2021 690 690
Accumulated deficit (7,903,742) (16,238,341)
Total Shareholders’ Deficit (7,903,052) (16,237,651)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT $ 239,677,950 $ 238,977,944